FDA — authorised 12 October 2018
- Application: NDA210331
- Marketing authorisation holder: ALIMERA SCIENCES INC
- Local brand name: YUTIQ
- Indication: IMPLANT — INTRAVITREAL
- Status: approved
FDA authorised Yutiq on 12 October 2018
Yes. FDA authorised it on 12 October 2018; FDA has authorised it.
ALIMERA SCIENCES INC holds the US marketing authorisation.